125 related articles for article (PubMed ID: 36928107)
1. Risk of adverse cardiovascular outcomes among people with HIV and nonalcoholic fatty liver disease.
Krishnan A; Sims OT; Surapaneni PK; Woreta TA; Alqahtani SA
AIDS; 2023 Jul; 37(8):1209-1216. PubMed ID: 36928107
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Outcomes and Mortality After Bariatric Surgery in Patients With Nonalcoholic Fatty Liver Disease and Obesity.
Krishnan A; Hadi Y; Alqahtani SA; Woreta TA; Fang W; Abunnaja S; Szoka N; Tabone LE; Thakkar S; Singh S
JAMA Netw Open; 2023 Apr; 6(4):e237188. PubMed ID: 37027156
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study.
Baratta F; Pastori D; Angelico F; Balla A; Paganini AM; Cocomello N; Ferro D; Violi F; Sanyal AJ; Del Ben M
Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2324-2331.e4. PubMed ID: 31887443
[TBL] [Abstract][Full Text] [Related]
4. Severity of Nonalcoholic Fatty Liver Disease is Associated With Cardiovascular Outcomes in Patients With Prehypertension or Hypertension: A Community-Based Cohort Study.
Song QR; Liu SL; Ling QH; Gao QN; Yang RX; Chen SH; Wu SL; Chen ML; Cai J
Front Endocrinol (Lausanne); 2022; 13():942647. PubMed ID: 36093080
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.
Pastori D; Sciacqua A; Marcucci R; Del Ben M; Baratta F; Violi F; Pignatelli P;
Intern Emerg Med; 2021 Nov; 16(8):2063-2068. PubMed ID: 33713286
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.
Simon TG; Roelstraete B; Hagström H; Sundström J; Ludvigsson JF
Gut; 2022 Sep; 71(9):1867-1875. PubMed ID: 34489307
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults.
Alexander M; Loomis AK; van der Lei J; Duarte-Salles T; Prieto-Alhambra D; Ansell D; Pasqua A; Lapi F; Rijnbeek P; Mosseveld M; Avillach P; Egger P; Dhalwani NN; Kendrick S; Celis-Morales C; Waterworth DM; Alazawi W; Sattar N
BMJ; 2019 Oct; 367():l5367. PubMed ID: 31594780
[TBL] [Abstract][Full Text] [Related]
8. Impact of nonalcoholic fatty liver disease on clinical outcomes in patients with COVID-19 among persons living with HIV: A multicenter research network study.
Krishnan A; Woreta TA; Sims OT; Hamilton JP; Potter JJ; Alqahtani SA
J Infect Public Health; 2023 May; 16(5):673-679. PubMed ID: 36931143
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection.
Krahn T; Martel M; Sapir-Pichhadze R; Kronfli N; Falutz J; Guaraldi G; Lebouche B; Klein MB; Wong P; Deschenes M; Ghali P; Sebastiani G
J Infect Dis; 2020 Aug; 222(5):787-797. PubMed ID: 32249283
[TBL] [Abstract][Full Text] [Related]
10. Brief Report: Relationship Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in Persons With HIV.
Kaplan A; Simon TG; Henson JB; Wang T; Zheng H; Osganian SA; Rosenblatt R; Lake J; Corey KE
J Acquir Immune Defic Syndr; 2020 Aug; 84(4):400-404. PubMed ID: 32235172
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
Chinnadurai R; Ritchie J; Green D; Kalra PA
Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
[TBL] [Abstract][Full Text] [Related]
12. Association of Bariatric Surgery With Cardiovascular Outcomes in Adults With Severe Obesity and Nonalcoholic Fatty Liver Disease.
Elsaid MI; Li Y; Bridges JFP; Brock G; Minacapelli CD; Rustgi VK
JAMA Netw Open; 2022 Oct; 5(10):e2235003. PubMed ID: 36205997
[TBL] [Abstract][Full Text] [Related]
13. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.
Chinnadurai R; Chrysochou C; Kalra PA
Nephron; 2019; 141(1):24-30. PubMed ID: 30384370
[TBL] [Abstract][Full Text] [Related]
14. Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan.
Yoneda M; Yamamoto T; Honda Y; Imajo K; Ogawa Y; Kessoku T; Kobayashi T; Nogami A; Higurashi T; Kato S; Hosono K; Saito S; Nakajima A
J Gastroenterol; 2021 Nov; 56(11):1022-1032. PubMed ID: 34601620
[TBL] [Abstract][Full Text] [Related]
15. The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study.
Park J; Kim G; Kim BS; Han KD; Kwon SY; Park SH; Lee YB; Jin SM; Kim JH
Cardiovasc Diabetol; 2022 Apr; 21(1):53. PubMed ID: 35429980
[TBL] [Abstract][Full Text] [Related]
16. Non-Alcoholic Fatty Liver Disease (NAFLD) and risk of new-onset heart failure: a retrospective analysis of 173,966 patients.
Roderburg C; Krieg S; Krieg A; Vaghiri S; Mohr R; Konrad M; Luedde M; Luedde T; Kostev K; Loosen SH
Clin Res Cardiol; 2023 Oct; 112(10):1446-1453. PubMed ID: 37410163
[TBL] [Abstract][Full Text] [Related]
17. Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study.
Kim JH; Moon JS; Byun SJ; Lee JH; Kang DR; Sung KC; Kim JY; Huh JH
Cardiovasc Diabetol; 2020 May; 19(1):51. PubMed ID: 32359355
[TBL] [Abstract][Full Text] [Related]
18. Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease.
Vieira Barbosa J; Milligan S; Frick A; Broestl J; Younossi Z; Afdhal N; Lai M
Am J Gastroenterol; 2022 Mar; 117(3):453-461. PubMed ID: 35041626
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study.
Sinn DH; Kang D; Chang Y; Ryu S; Cho SJ; Paik SW; Song YB; Pastor-Barriuso R; Guallar E; Cho J; Gwak GY
J Gastroenterol Hepatol; 2020 May; 35(5):833-839. PubMed ID: 31512278
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study.
Park H; Dawwas GK; Liu X; Nguyen MH
J Intern Med; 2019 Dec; 286(6):711-722. PubMed ID: 31359543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
